Sepetinizde ürün bulunmuyor.

Prof Dr. Ercüment Karasulu

Prof Dr. Ercüment Karasulu

Eğitim ve Uzmanlık

  • Ege Üniversitesi (Egitim Alt Alanı: FARMASÖTIK TEKNOLOJI)

Bilimsel Teknolojik Faaliyet Alanı Bilgileri

  • Saglık Bilimleri
  • Eczacılık
  • Eczacılık Teknolojisi
  • Farmasötik Teknoloji
  • Biyofarmasötik ve Farmakokinetik

Deneyim / İşyeri Bilgileri

  • 01 Ocak 1986 – Su Anda (38 yıl 3 ay) (Tam Zamanlı)
    PROF. DR., PROF. DR., DIGER (Ege Üniversitesi )
    Idari Görev: DIGER
  • 01 Ocak 1986 – 01 Ocak 2013 (27 yıl 1 ay) (Tam Zamanlı)
    DOÇ. DR., DOÇ. DR., DIGER (Ege Üniversitesi )
    Idari Görev: DIGER
  • 01 Ocak 1986 – 01 Ocak 2009 (23 yıl 1 ay) (Tam Zamanlı)
    DOKTORALI ÖGRETIM ÜYESI, YRD. DOÇ. DR., DIGER (Ege Üniversitesi )
    Idari Görev: DIGER

Araştırma Yayınları

  • H. Y. KARASULU, E. GUNDOGDU, T. TURGAY, U. O. TURK, S. APAYDIN, I. Y. SIMSIR,
    C. YILMAZ & E. KARASULU, Development and Optimization of Self-emulsifying
    Drug Delivery Systems (SEDDS) for Enhanced Dissolution and Permeability of
    Rosuvastatin, CURRENT DRUG DELIVERY, 2016, 1567-2018, 13, 3, 362-370.
  • Y. BASPINAR, E. GUNDOGDU, C. KOKSAL, H. Y. KARASULU, N. U. K. YAVASOGLU &
    E. KARASULU, Hepatotoxicity, Acute Toxicity and Salmonella/Microsome
    Mutagenicity Assay (Ames) of Imatinib Microemulsions, LATIN AMERICAN
    JOURNAL OF PHARMACY, 2016, 0326-2383, 35, 1, 98-104.
  • A. OLCER, M. OLCER, I. INCE & E. KARASULU, The advantages of combination
    therapy on hypertension: development of immediate release perindoprilindapamide
    tablet and assessment of bioequivalence studies, PHARMACEUTICAL
    DEVELOPMENT AND TECHNOLOGY, 2016, 1083-7450, 21, 2, 239-249.
  • M. OLCER, A. OLCER, I. INCE & E. KARASULU, Development and in vitro/in vivo
    evaluation of immediate release perindopril tablets, PHARMACEUTICAL
    DEVELOPMENT AND TECHNOLOGY, 2015, 1083-7450, 20, 6, 684-693.
  • Y. BASPINAR, E. GUNDOGDU, C. KOKSAL & E. KARASULU, Pitavastatin-containing
    nanoemulsions: Preparation, characterization and in vitro cytotoxicity, JOURNAL
    OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2015, 1773-2247, 29, 117-
    124.
  • E. KARASULU, Y. B. C. K. I. I. E. K. EVREN GUNDOGDU & Y. B. C. K. I. I. E. K. EVREN
    GUNDOGDU, A Microemulsion for the Oral Drug Delivery of Pitavastatin,
    Pharmaceut Anal Acta, 2013, 0000-0000, 4, 1, 1000209-1-5.
  • C. CINGI, S. Z. TOROS, I. INCE, C. K. ERTUGAY, M. K. GURBUZ, H. CAKLI, N.
    ERDOGMUS, E. KARASULU & E. KAYA, Does Desloratadine Alter the Serum Levels
    of Montelukast When Administered in a Fixed-Dose Combination?,
    LARYNGOSCOPE, 2013, 0023-852X, 123, 11, 2610-2614.
  • C. CINGI, S. Z. TOROS, M. K. GURBUZ, I. INCE, H. CAKLI, N. ERDOGMUS, E.
    KARASULU & E. KAYA, Effect of grapefruit juice on bioavailability of montelukast,
    LARYNGOSCOPE, 2013, 0023-852X, 123, 4, 816-819.